3-(4'-Bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease
申请人:SUGEN, INC.
公开号:US20030176487A1
公开(公告)日:2003-09-18
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.